Reliability and Validity of SARC-F Questionnaire to Assess Sarcopenia Among Vietnamese Geriatric Patients
Received 18 March 2020
Accepted for publication 1 May 2020
Published 9 June 2020 Volume 2020:15 Pages 879—886
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Richard Walker
Tam Ngoc Nguyen,1,2 Anh Trung Nguyen,1,2 Long Quynh Khuong,3 Thanh Xuan Nguyen,1,2 Huong Thi Thu Nguyen,1,2 Thu Thi Hoai Nguyen,1,2,4 Minh Van Hoang,3 Thang Pham,1,2 Tu Ngoc Nguyen,5 Huyen Thi Thanh Vu1,6
1Department of Geriatrics, Hanoi Medical University, Hanoi, Vietnam; 2Scientific Research Department, National Geriatric Hospital, Hanoi, Vietnam; 3Hanoi University of Public Health, Hanoi, Vietnam; 4Dinh Tien Hoang Institute of Medicine, Hanoi, Vietnam; 5Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; 6Hanoi Medical University Hospital, Hanoi, Vietnam
Correspondence: Huyen Thi Thanh Vu
Department of Geriatrics, Hanoi Medical University, 01 Ton That Tung, Dong Da, Hanoi, Vietnam
Background: The SARC-F questionnaire has been developed as a rapid diagnostic test that can be used to screen for sarcopenia.
Aim: To investigate the reliability and validity of the Vietnamese version of SARC-F as a screening tool for sarcopenia in older patients in Vietnam.
Methods: A cross-sectional study was conducted in older people attending the outpatient clinics of the National Geriatric Hospital in Vietnam. Muscle mass (using dual-energy X-ray absorptiometry), handgrip strength and gait speed were assessed. SARC-F was validated against the three standard criteria for sarcopenia: the Foundation for the National Institutes of Health (FNIH), Asia Working Group for Sarcopenia (AWGS 2019) and European Working Group on Sarcopenia in Older People (EWGSOP2).
Results: There were 764 participants (mean age 71.5 ± 8.9 years). The Vietnamese SARC-F questionnaire had a good internal consistency (Cronbach’s alpha 0.85). The prevalence of sarcopenia was 49.2% according to SARC-F and 48.3%, 61.1% and 52.6% according to FNIH, AWGS 2019 and EWGSOP2, respectively. The sensitivity and specificity of SARC-F in identifying sarcopenia were 67.1% and 66.7% (for FINH), 66.7% and 67.1% (for AWGS 2019), and 64.9% and 68.2% (for EWGSOP2). The AUCs of SARC-F were 0.71– 0.72 against the three sarcopenia criteria.
Conclusion: The Vietnamese version of SARC-F questionnaire has acceptable diagnostic value for sarcopenia. SARC-F could be used as an initial screening for sarcopenia in hospital clinics.
Keywords: older patients, sarcopenia, SARC-F, Vietnam
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]